Filing Flows › Ultragenyx Pharmaceutical (RARE) › Recalls, complaints & regulation
Ultragenyx Pharmaceutical (RARE): clinical trials
Ultragenyx Pharmaceutical (RARE) beyond its filings: 16 active clinical trials.
Ultragenyx Pharmaceutical's latest quarter
Ultragenyx Pharmaceutical, Q3 2026: revenue $173M (+8% year over year), operating margin -63.6%, net loss $118M, operating cash flow −$43.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Ultragenyx Pharmaceutical have?
16 active studies on ClinicalTrials.gov, 7 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.